GNLX compared with CRIS: revenue, margins and what each company keeps, and the suppliers and customers both name

GNLXGenelux Corp

Mkt capRevenueRevenue

CRISCuris Inc

Mkt capRevenueRevenue

Compare

GNLXGenelux Corp

CRISCuris Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GNLX: latest quarter is a loss; flow not drawable. CRIS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GNLX 2

—Newsoaraunlistedcustomer

—Newsoara BioPharmaunlistedcustomer

Shared 0

No shared counterparties.

Only CRIS 1

—Genentechunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

GNLXGenelux Corp

2.03▼−2.63%

Mkt cap$94.1MRevenue$8,000Q4 FY25Revenue—

CRISCuris Inc

0.72▲+19.43%

Regular sessionNov 2 '26

Mkt cap$1.3MRevenue$1MQ4 FY25Revenue$9MFY25

Compare

Regular sessionNov 2 '26

GNLXGenelux Corp

CRISCuris Inc

2.03▼−2.63%

Price

0.72▲+19.43%

$94.1M

Mkt cap

$1.3M

Q4 FY25$8,000

Revenue

$1MQ4 FY25

—

Revenue

$9MFY25

GNLX2.03▼−2.63%vsCRIS0.72▲+19.43%Regular sessionNov 2 '26

Price

rebased to 0%

GNLX, solidCRIS, dashed